Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism: A Randomized Clinical Trial

BACKGROUND AND OBJECTIVES: Vitamin D receptor activators and calcimimetics (calcium-sensing receptor agonists) are two major options for medical treatment of secondary hyperparathyroidism. A higher serum calcification propensity (a shorter T(50) value) is a novel surrogate marker of calcification st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Main Authors: Shoji, Tetsuo, Nakatani, Shinya, Kabata, Daijiro, Mori, Katsuhito, Shintani, Ayumi, Yoshida, Hisako, Takahashi, Kanae, Ota, Keiko, Fujii, Hisako, Ueda, Shinichiro, Nishi, Shinichi, Nakatani, Tatsuya, Yoshiyama, Minoru, Goto, Kiyoshi, Hamada, Takayoshi, Imanishi, Masahito, Ishimura, Eiji, Kagitani, Sosuke, Kato, Yoshikazu, Kumeda, Yasuro, Maekawa, Kiyoshi, Matsumura, Takayasu, Nagayama, Harumi, Obi, Yasue, Ohno, Yoshiteru, Sai, Yoshinori, Sakurai, Mayumi, Sasaki, Satoshi, Shidara, Kaori, Shoji, Shigeichi, Tsujimoto, Yoshihiro, Yamakawa, Kenjiro, Yasuda, Hideaki, Yodoi, Shozo, Inaba, Masaaki, Emoto, Masanori
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092049/
https://ncbi.nlm.nih.gov/pubmed/33685864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.16601020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados